Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD

Experimental and Clinical Psychopharmacology

Volumn 13, Issue 2, 2005, Pages 111-126

  Pelham, William E ^a,b   Burrows MacLean, Lisa ^a,b   Gnagy, Elizabeth M ^a,b   Fabiano, Gregory A ^a,b   Coles, Erika K ^a,b   Tresco, Katy E ^a,b   Chacko, Anil ^a,b   Wymbs, Brian T ^a,b   Wienke, Amber L ^a,b   Walker, Kathryn S ^a,b   Hoffman, Martin T ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Attention deficit hyperactivity disorder; Behavioral treatment; Combined treatment; Methylphenidate

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR MODIFICATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EMOTIONALITY; FEMALE; HUMAN; INSOMNIA; LOW DRUG DOSE; MALE; MOTOR DYSFUNCTION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN IRRITATION; SKIN MANIFESTATION; SUMMER; TIC; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PSYCHIATRIC STATUS RATING SCALES; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 20344375922     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.13.2.111     Document Type: Article

References (88)

1. Abramowitz, A. J., Eckstrand, D., O'Leary, S. G., & Dulcan, M. K. (1992). ADHD children's responses to stimulant medication and two intensities of a behavioral intervention. Behavior Modification, 16, 193-203.
2. American Academy of Child and Adolescent Psychiatry. (2002). Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 26S-49S.
3. American Academy of Pediatrics. (2001). Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics, 108, 1033-1044.
4. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
5. Atkins, M. S., Pelham, W. E., & Licht, M. H. (1985). A comparison of objective classroom measures and teacher ratings of attention deficit disorder. Journal of Abnormal Child Psychology, 13, 155-167.
6. Atkins, M. S., Pelham, W. E., & White, K. J. (1989). Hyperactivity and attention deficit disorders. In M. Hersen (Ed.), Psychological aspects of developmental and physical disabilities: A casebook (pp. 137-156). Thousand Oaks, CA: Sage.
7. Biederman, J., Lopez, F. A., Boellner, S. W., & Chandler, M. C. (2002). A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder. Pediatrics, 110, 258-266.
8. Carlson, C. L., Pelham, W. E., Milich, R., & Dixon, M. J. (1992). Single and combined effects of methylphenidate and behavior therapy on the classroom behavior, academic performance and self-evaluations of children with attention deficit-hyperactivity disorder. Journal of Abnormal Child Psychology, 20, 213-232.
9. Chronis, A. M., Fabiano, G. A., Gnagy, E. M., Onyango, A. N., Pelham, W. E., Williams, A., et al. (2004). An evaluation of the summer treatment program for children with attention-deficit/hyperactivity disorder using a treatment withdrawal design. Behavior Therapy, 35, 561-585.
10. Chronis, A. M., Pelham, W. E., Gnagy, E. M., Roberts, J. E., & Aronoff, H. R. (2003). The impact of late-afternoon stimulant dosing for children with ADHD on parent and parent-child domains. Journal of Clinical Child Psychology, 32, 118-126.
11. Coles, E. K., Pelham, W. E., Gnagy, E. M., Burrows-MacLean, L., Fabiano, G. A., Chacko, A., et al. Treatment response to a comprehensive behavioral intervention. Journal of Emotional and Behavioral Disorders.
12. Cunningham, C. E., Bremner, R., & Secord-Gilbert, M. (1998). The community parent education (COPE) program: A school-based family systems oriented course for parents of children with disruptive behavior disorders. Hamilton, Canada: Chedoke-McMaster Hospitals and McMaster University.
13. Dishion, T. J., McCord, J., & Poulin, F. (1999). When interventions harm: Peer groups and problem behavior. American Psychologist, 54, 755-764.
14. DuPaul, G. J., & Eckert, T. L. (1997). The effects of school-based interventions for attention deficit hyperactivity disorder: A meta-analysis. School Psychology Review, 26, 5-21.
15. Evans, S. W., Pelham, W. E., Smith, B. H., Bukstein, O., Gnagy, E. M., Greiner, A. R., et al. (2001). Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD. Experimental and Clinical Psychopharmacology, 9, 163-175.
16. Fabiano, G. A., & Pelham, W. E. (2002). Evidence-based treatment for mental disorders in children and adolescents. Current Psychiatry Reports, 4, 93-100.
17. th annual convention of the Association for Advancement of Behavior Therapy, Reno, NV.
18. Fabiano, G. A., Pelham, W. E., Gnagy, E. M., Burrows-MacLean, L., Massetti, G. M., & Hoffman, M. T. (2003, November). The single and combined effects of three intensities of behavior modification and four intensities of medication in a summer treatment program classroom. Poster session presented at the 37th annual convention of the Association for Advancement of Behavior Therapy, Boston, MA.
19. Fabiano, G. A., Pelham, W. E., Manos, M. J., Gnagy, E. M., Chronis, A. M., Onyango, A. N., et al. (2004). An evaluation of three time-out procedures for children with attention-deficit/hyperactivity disorder. Behavior Therapy, 35, 449-469.
20. Fabiano, G. A., Pelham, W., Pisecco, S., Hannah, J., Evans, S., Manos, M., et al. (2001, April). Nationally representative survey of treatment for ADHD in the school setting: Preliminary results. Paper presented at the 8th Florida conference on Child Health Psychology, Gainesville, FL.
21. Goldman, L. S., Genel, M., Bezman, R. J., & Slanetz, P. J. (1998). Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Journal of the American Medical Association, 279, 1100-1107,
22. Goyette, C., Conners, C., & Ulrich, R. (1978). Normative data on revised Conners parents and teacher rating scales. Journal of Abnormal Child Psychology, 6, 221-236.
23. Greenhill, L. L., Abikoff, H. B., Arnold, L. E., Cantwell, D. P., Conners, C. K., Elliott, G., et al. (1996). Medication treatment strategies in the MTA study: Relevance to clinicians and researchers. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1304-1313.
24. Greenhill, L. L., Halperin, H. M., & Abikoff, H. (1999). Stimulant medications. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 503-512.
25. Hinshaw, S. P., Klein, R. G., & Abikoff, H. (1998). Childhood attention deficit hyperactivity disorder: Nonpharmacological and combination treatments. In P. E. Nathan & J. M. Gorman (Eds.), A guide to treatments that work (pp. 3-23). New York: Oxford University Press.
26. Horn, W. F., Ialongo, N. S., Pascoe, J. M., Greenberg, G., Packard, T., Lopez, M., et al. (1991). Additive effects of psychostimulants, parent training, and self-control therapy with ADHD children. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 233-240.
27. Hoza, B., Pelham, W. E., Dobbs, J., Owens, J. S., & Pillow, D. R. (2002). Do boys with attention-deficit/hyperactivity disorder have positive illusory self concepts? Journal of Abnormal Psychology, 111, 268-278.
28. Hoza, B., Pelham, W. E., Sams, S. E., & Carlson, C. L. (1992). An examination of the "dosage" effects of both behavior therapy and methylphenidate on the classroom performance of two ADHD children. Behavior Modification, 16, 164-192.
29. Hoza, B., Waschbusch, D. A., Owens, J. S., Pelham, W. E., & Kipp, H. (2001). Academic task persistence of normally achieving ADHD and control boys: Performance, self-evaluations, and attributions. Journal of Consulting and Clinical Psychology, 69, 271-283.
30. Hoza, B., Waschbusch, D. A., Pelham, W. E., Molina, B. S. G., & Milich, R. (2000). Attention-deficit/hyperactivity disordered and control boys' responses to social success and failure. Child Development, 71, 432-446.
31. Jacob, R., & Pelham, W. E. (1999). Behavior therapy. In H. Kaplan & B. Sadock (Eds.), Comprehensive textbook of psychiatry (Vol. 2, 7th ed., pp. 2080-2127). New York: Williams & Wilkins.
32. Jadad, A. R., Boyle, M., Cunningham, C., Kim, M., & Schachar, R. (1999). Treatment of attention-deficit hyperactivity disorder (Evidence Rep./Technology Assessment No. 11). Rockville, MD: Agency for Healthcare Research and Quality.
33. Jensen, P. S., & Payne, J. (1998). Behavioral and medical treatments for attention deficit hyperactivity disorder: Comparisons and combinations. In NIH Consensus Development Conference: Diagnosis and treatment of attention deficit hyperactivity disorder (pp. 143-155). Bethesda, MD: National Institutes of Health, Office of the Director.
34. Klein, R. G., & Abikoff, H. (1997). Behavior therapy and methylphenidate in the treatment of children with ADHD. Journal of Attention Disorders, 2, 89-114.
35. Loney, J., & Milich, R. (1982). Hyperactivity, inattention, and aggression in clinical practice. In M. Wolraich & D. K. Routh (Eds.), Advances in developmental and behavioral pediatrics (Vol. 3, pp. 113-147). Greenwich, CT: JAI Press.
36. Lopez, F., Pistreich, L., Lee, J., & Muniz, R. (2003, May). Comparative efficacy of two long-acting formulations of methylphenidate and placebo. Poster session presented at the 43rd annual meeting of New Clinical Drug Evaluation Unit, Boca Raton, FL.
37. Miller, A., Lee, S., Raina, P., Klassen, A., Zupancic, J., & Olsen, L. (1998). A review of therapies for attention-deficit/hyperactivity disorder. Ottawa: Canadian Coordinating Office for Health Technology Assessment.
38. MTA Cooperative Group. (1999). 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder. Archives of General Psychiatry, 56, 1073-1086.
39. MTA Cooperative Group. (2004). National Institute of Mental Health multimodal treatment study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment. Pediatrics, 113, 762-769.
40. National Institutes of Health. (1998). Diagnosis and treatment of attention deficit hyperactivity disorder. NIH Consensus Statement, 16(2), 1-37.
41. Northup, J., Fusilier, I., Swanson, V., Huerte, J., Bruce, T., Freeland, J., et al. (1999). Further analysis of the separate and interactive effects of methylphenidate and common classroom contingencies. Journal of Applied Behavior Analysis, 32, 35-50.
42. O'Leary, K. D., Pelham, W. E., Rosenbaum, A., & Price, G. H. (1976). Behavioral treatment of hyperkinetic children: An experimental evaluation of its usefulness. Clinical Pediatrics, 15, 510-515.
43. Onyango, A. N., Pelham, W. E., Gnagy, E., Massetti, G. M., Burrows-MacLean, L., & Fabiano, G. (2003, November). The impact of treatment on deviancy training in children with ADHD. Poster session presented at the 37th annual convention of the Association for Advancement of Behavior Therapy, Boston.
44. Pelham, W. E. (1993). Pharmacotherapy for children with attention-deficit hyperactivity disorder. School Psychology Review, 22, 199-227.
45. Pelham, W. E. (1999). The NIMH Multimodal Treatment Study for attention-deficit hyperactivity disorder: Just say yes to drugs alone? Canadian Journal of Psychiatry, 44, 981-990.
46. Pelham, W. E., Aronoff, H. R., Midlam, J. K., Shapiro, C. J., Gnagy, E. M., Chronis, A. M., et al. (1999). A comparison of Ritalin and Adderall: Efficacy and time-course in children with attention-deficit/hyperactivity disorder. Pediatrics Electronic Pages, 103, e43. Retrieved April 5, 1999, from http://pediatrics .aappublications.org/cgi/content/full/103/4/e43
47. Pelham, W. E., Bender, M. E., Caddell, J., Booth, S., & Moorer, S. (1985). The dose-response effects of methylphenidate on classroom academic and social behavior in children with attention deficit disorder. Archives of General Psychiatry, 42, 948-952.
48. Pelham, W. E., Burrows-MacLean, L., Gnagy, E. M., Coles, E. K., Wymbs, B. T., Chacko, A., et al. (2003, November). A dose-ranging study of behavioral and pharmacological treatment for children with ADHD. Poster session presented at the annual convention of the Association for the Advancement of Behavior Therapy, Boston.
49. Pelham, W. E., Carlson, C. L., Sams, S. E., Vallano, G., Dixon, M. J., & Hoza, B. (1993). Separate and combined effects of methylphenidate and behavior modification on boys with attention deficit-hyperactivity disorder in the classroom. Journal of Consulting and Clinical Psychology, 61, 506-515.
50. Pelham, W. E., Fabiano, G. A., Gnagy, E. M., Greiner, A. R., Hoza, B., Manos, M., & Janakovic, F. (2005). Comprehensive psychosocial treatment for ADHD. In E. Hibbs & P. Jensen (Eds.), Psychosocial treatments for child and adolescent disorders: Empirically based strategies for clinical practice (2nd ed., pp. 377-410). Washington, DC: American Psychological Association.
51. Pelham, W. E., Fabiano, G. A., & Massetti, G. M. (in press). Evidence-based assessment for attention-deficit/hyperactivity disorder in children and adolescents. Journal of Clinical Child and Adolescent Psychology.
52. Pelham, W. E., Gnagy, E. M., Burrows-MacLean, L., Williams, A., Fabiano, G. A., Morrisey, S. M., et al. (2001). Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics Electronic Pages, 107, e105. Retrieved June 4, 2001, from http:// www.pediatrics.org/cgi/content/full/107/106/e105
53. Pelham, W. E., Gnagy, E. M., Chronis, A. M., Burrows-MacLean, L., Fabiano, G. A., Onyango, A. N., et al. (1999). A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics, 104, 1300-1311.
54. Pelham, W. E., Gnagy, E. M., Greenslade, K. E., & Milich, R. (1992). Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 210-218.
55. Pelham, W. E., Gnagy, E. M., Greiner, A. R., Hoza, B., Hinshaw, S. P., Swanson, J. M., et al. (2000). Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. Journal of Abnormal Child Psychology, 28, 507-526.
56. Pelham, W. E., Greenslade, K. E., Vodde-Hamilton, M. A., Murphy, D. A., Greenstein, J. J., Gnagy, E. M., et al. (1990). Relative efficacy of long-acting CNS stimulants on children with attention deficit-hyperactivity disorder: A comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics, 86, 226-237.
57. Pelham, W. E., Greiner, A. R., & Gnagy, E. M. (1997). Summer Treatment Program Manual. Buffalo, NY: Comprehensive Treatment for Attention Deficit Disorders.
58. Pelham, W. E., & Hoza, B. (1996). Comprehensive treatment for ADHD: Intensive summer treatment programs and follow-up. In E. D. Hibbs & P. S. Jensen (Eds.), Psychosocial treatments for child and adolescent disorders (pp. 311-340). Washington, DC: American Psychological Association.
59. Pelham, W. E., Hoza, B., Kipp, H. L., Gnagy, E. M., & Trane, S. T. (1997). Effects of methylphenidate and expectancy on ADHD children's performance, self evaluations, persistence, and attributions on a cognitive task. Experimental and Clinical Psychopharmacology, 5, 3-13.
60. Pelham, W. E., Hoza, B., Pillow, D. R., Gnagy, E. M., Kipp, H. L., Greiner, A. R., et al. (2002). Effects of methylphenidate and expectancy on children with ADHD: Behavior, academic performance, and attributions in a summer treatment program and regular classroom setting. Journal of Consulting and Clinical Psychology, 70, 320-335.
61. Pelham, W. E., Lang, A. R., Atkeson, B., Murphy, D. A., Gnagy, E. M., Greiner, A. R., et al. (1997). Effects of deviant child behavior on parental distress and alcohol consumption in laboratory interactions. Journal of Abnormal Child Psychology, 25, 413-424.
62. Pelham, W. E., Manos, M. J., Ezzell, C. E., Tresco, K. E., Gnagy, E. M., Hoffman, M. T., et al. (in press). A dose ranging study of a methylphenidate transdermal system in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry.
63. Pelham, W. E., Murphy, D. A., Vanatta, K., Milich, R., Licht, B. G., Gnagy, E. M., et al. (1992). Methylphenidate and attributions in boys with attention deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology, 60, 282-292.
64. Pelham, W. E., & Murphy, H. A. (1986). Attention deficit and conduct disorders. In M. Hersen (Ed.), Pharmacological and behavioral treatment: An integrative approach (pp. 108-148). New York: Wiley.
65. Pelham, W. E., Schentag, J., Gnagy, E. M., Panahon, C., Ballow, C., Fabiano, G. A., et al. (2005). A methylphenidate transdermal system versus t.i.d. methylphenidate in a laboratory setting. Unpublished manuscript.
66. Pelham, W. E., Schnedler, R. W., Bender, M. E., Miller, J., Nilsson, D., Budrow, M., et al. (1988). The combination of behavior therapy and methylphenidate in the treatment of hyperactivity: A therapy outcome study. In L. Bloomingdale (Ed.), Attention deficit disorders (Vol. 3, pp. 29-48). London: Pergamon Press.
67. Pelham, W. E., Schnedler, R. W., Bologna, N. C., & Contreras, J. A. (1980). Behavioral and stimulant treatment of hyperactive children: A therapy study with methylphenidate probes in a within-subject design. Journal of Applied Behavior Analysis, 13, 221-236.
68. Pelham, W. E., Sturges, J., Hoza, J., Schmidt, C. W., Bijlsma, J. J., Milich, R., et al. (1987). Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder. Pediatrics, 80, 491-501.
69. Pelham, W. E., Swanson, J. M., Furman, M. B., & Schwindt, H. (1995). Pemoline effects on children with ADHD: A time-response by dose-response analysis on classroom measures. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1504-1513.
70. Pelham, W. E., Walker, J. L., Sturges, J., & Hoza, J. (1989). Comparative effects of methylphenidate on ADD girls and ADD boys. Journal of the American Acdemy of Child and Adolescent Psychiatry, 28, 773-776.
71. Pelham, W. E., & Waschbusch, D. A. (1999). Behavioral interventions in attention deficit/hyperactivity disorder. In H. Quay & A. Hogan (Eds.), Handbook of disruptive behavior disorders (pp. 255-278). New York: Kluwer Academic.
72. Pelham, W. E., Waschbusch, D. A., Hoza, B., Pillow, D. R., & Gnagy, E. M. (2001). Effects of methylphenidate and expectancy on performance, self-evaluations, persistence, and attributions on a social task in boys with ADHD. Experimental and Clinical Psychopharmacology, 9, 502-506.
73. Pelham, W. E., Wheeler, T., & Chronis, A. M. (1998). Empirically supported psychosocial treatments for ADHD. Journal of Child Clinical Psychology, 27, 189-204.
74. Psychological Corporation. (2002). Wechsler Individual Achievement Test: Second ed. Examiner's manual. San Antonio, TX: Harcourt Brace & Company.
75. Shaffer, D., Fisher, P., Lucas, C. P., Dulcan, M. K., & Schwab-Stone, M. E. (2000). NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): Description, differences from previous versions, and reliability of some common diagnoses. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 28-38.
76. Smith, B. H., Pelham, W. E., Evans, S., Molina, B., Gnagy, E., Greiner, A., et al. (1998). Dosage effects of methylphenidate on the social behavior of adolescents diagnosed with attention deficit hyperactivity disorder. Experimental and Clinical Psychopharmacology, 6, 1-18.
77. Spencer, T., Biederman, J., Wilens, T., Harding, M., O'Donnell, D., & Griffin, S. (1996). Pharmacotherapy of ADHD across the life cycle. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 409-432.
78. Swanson, J. M., Kinsbourne, M., Roberts, W., & Zucker, K. (1978). Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics, 61, 21-29.
79. Swanson, J. M., Lerner, M., Wigal, T., Steinhoff, K., Greenhill, L., Posner, K., et al. (2002). The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications. Journal of Attention Disorders, 6(Suppl. 1), S73-S88.
80. Swanson, J. M., McBurnett, K., Christian, D. L., & Wigal, T. (1995). Stimulant medications and the treatment of children with ADHD. In T. H. Ollendick & R. J. Prinz (Eds.), Advances in clinical child psychology (Vol. 17, pp. 265-322). New York: Plenum Press.
81. Swanson, J. M., Wigal, S., Greenhill, L., Browne, R., Waslick, B., Lerner, M., et al. (1998). Analog classroom assessment of Adderall in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 519-526.
82. Vitiello, B., Severe, J. B., Greenhill, L. L., Arnold, L. E., Abikoff, H. B., Bukstein, O. G., et al. (2001). Methylphenidate dosage for children with ADHD over time under controlled conditions: Lessons from the MTA. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 188-196.
83. Walker, H. M., Ramsey, E., & Gresham, F. M. (2003-2004, Winter). Heading off disruptive behavior: How early intervention can reduce defiant behavior- and win back teaching time. American Educator. Retrieved October 18, 2004, from http://www.aft.org/pubs-reports/american_educator/winter03-04/ early_intervention.html
84. Waschbusch, D. A., Kipp, H. L., & Pelham, W. E., Jr. (1998). Generalization of behavioral and psychostimulant treatment of attention-deficit/hyperactivity disorder (ADHD): Discussion and examples. Behaviour Research and Therapy, 36, 675-694.
85. Werry, J. S., & Sprague, R. L. (1974). Methylphenidate in children-effect of dosage. Australian and New Zealand Journal of Psychiatry, 8, 9-19.
86. Wechsler, D. (1991). Wechsler Intelligence Scale for Children (3rd ed.). San Antonio, TX: Psychological Corporation.
87. Wigal, T., Swanson, J. M., Regino, R., Lerner, M. A., Soliman, I., Steinhoff, K., et al. (1999). Stimulant medications for the treatment of ADHD: Efficacy and limitations. Mental Retardation and Developmental Disabilities Research Reviews, 3, 215-224.
88. Wolraich, M. L., Greenhill, L. L., Pelham, W. E., Swanson, J., Wilens, T., Palumbo, D., et al. (2001). Randomized, controlled trial of OROS® methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics, 108, 883-892.